Page 2 - Rd Fund News Today

Wednesday, vTv Therapeutics Inc VTVT shares are soaring on a robust session volume of 2.7 million, compared to the average volume of 31.92 K as per the data…

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling around 100 points on Wednesday. The Dow traded down 0.27% to 38,867.91 while the NASDAQ fell 0.50% to 15,954.75. The S&P 500 also fell, dropping, 0.18% to 5,068.92.

Transplant of HIP-modified pancreatic islet cells provided lasting glucose control in a fully immunocompetent non-human primate , enabling the achievement of exogenous insulin independence without...

Cour Pharmaceuticals’ nanoparticles reprogram the immune system to stop inflammation behind autoimmune disease. Three big pharma companies joined the startup’s Series A financing, which will fund clinical trials in type 1 diabetes and myasthenia gravis.

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Private sector will give 6% of income to govt’s R&D Fund

Seraxis Manufacturing Suite Completes GMP Quality System Audit Ahead ...

SIOUX FALLS, S.D., Nov. 20, 2023 -- SAB Biotherapeutics , a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing a fully-human anti-thymocyte...

SIOUX FALLS, S.D., Nov. 20, 2023 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (NASDAQ:SABS), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing a fully-human anti-thymocyte

ISLAMABAD: The Economic Coordination Committee (ECC) of the Cabinet has allowed release of Rs 5 billion for one-time...